Filter News
Area of Research
- (-) Nuclear Science and Technology (13)
- Biological Systems (1)
- Biology and Environment (22)
- Clean Energy (20)
- Computational Biology (1)
- Computational Engineering (1)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (9)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (7)
- Materials (50)
- Materials for Computing (6)
- National Security (5)
- Neutron Science (21)
- Supercomputing (48)
News Type
News Topics
- (-) Advanced Reactors (7)
- (-) Biomedical (1)
- (-) Physics (2)
- (-) Space Exploration (3)
- 3-D Printing/Advanced Manufacturing (4)
- Bioenergy (1)
- Computer Science (2)
- Coronavirus (1)
- Cybersecurity (1)
- Decarbonization (1)
- Environment (1)
- Fusion (7)
- Isotopes (4)
- Materials Science (3)
- Molten Salt (1)
- Neutron Science (3)
- Nuclear Energy (26)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
After more than a year of operation at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), the COHERENT experiment, using the world’s smallest neutrino detector, has found a big fingerprint of the elusive, electrically neutral particles that interact only weakly with matter.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.